Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat
- PMID: 26719892
- PMCID: PMC4700991
- DOI: 10.1371/journal.ppat.1005258
Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures

Similar articles
-
Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.Chest. 1988 Aug;94(2 Suppl):97S-169S. Chest. 1988. PMID: 3396440 No abstract available.
-
Respiratory tract infections in cystic fibrosis.Pediatr Ann. 2002 Feb;31(2):116-23. doi: 10.3928/0090-4481-20020201-09. Pediatr Ann. 2002. PMID: 11862722 Review. No abstract available.
-
Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.Thorax. 1990 Nov;45(11):881-4. doi: 10.1136/thx.45.11.881. Thorax. 1990. PMID: 2256020 Free PMC article. Review. No abstract available.
-
Antibiotic management of cystic fibrosis.J Antimicrob Chemother. 1976 Jun;2(2):107-9. doi: 10.1093/jac/2.2.107. J Antimicrob Chemother. 1976. PMID: 956076 No abstract available.
-
Antibiotic therapy for bronchopulmonary infections in cystic fibrosis. The American approach.Antibiot Chemother (1971). 1989;42:229-36. doi: 10.1159/000417624. Antibiot Chemother (1971). 1989. PMID: 2688544 Review. No abstract available.
Cited by
-
Interactions between Pseudomonas aeruginosa and six opportunistic pathogens cover a broad spectrum from mutualism to antagonism.Environ Microbiol Rep. 2024 Oct;16(5):e70015. doi: 10.1111/1758-2229.70015. Environ Microbiol Rep. 2024. PMID: 39356147 Free PMC article.
-
Updated Review on the Mechanisms of Pathogenicity in Mycobacterium abscessus, a Rapidly Growing Emerging Pathogen.Microorganisms. 2022 Dec 29;11(1):90. doi: 10.3390/microorganisms11010090. Microorganisms. 2022. PMID: 36677382 Free PMC article. Review.
-
Three Distinct Contact-Dependent Growth Inhibition Systems Mediate Interbacterial Competition by the Cystic Fibrosis Pathogen Burkholderia dolosa.J Bacteriol. 2018 Oct 23;200(22):e00428-18. doi: 10.1128/JB.00428-18. Print 2018 Nov 15. J Bacteriol. 2018. PMID: 30150233 Free PMC article.
-
Genomic Analysis Identifies Novel Pseudomonas aeruginosa Resistance Genes under Selection during Inhaled Aztreonam Therapy In Vivo.Antimicrob Agents Chemother. 2019 Aug 23;63(9):e00866-19. doi: 10.1128/AAC.00866-19. Print 2019 Sep. Antimicrob Agents Chemother. 2019. PMID: 31285231 Free PMC article.
-
Mathematical models of cystic fibrosis as a systemic disease.WIREs Mech Dis. 2023 Nov-Dec;15(6):e1625. doi: 10.1002/wsbm.1625. Epub 2023 Aug 6. WIREs Mech Dis. 2023. PMID: 37544654 Free PMC article. Review.
References
-
- Rogers GB, Hart CA, Mason JR, Hughes M, Walshaw MJ, et al. (2003) Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 41: 3548–3558. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical